US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price

US CMS recommends 30% increase for Pacific Edge's Cxbladder Triage Plus price
(Image: Supplied)
Staff reporters
Cancer diagnostics company Pacific Edge has announced that the United States' Centers for Medicare & Medicaid Services (CMS) recommended a final “gapfill” price for its Cxbladder Triage Plus.CMS is proposing a price of US$1,328.32 (NZ$2,241.71), which is about 30% higher than the US$1,018 draft price proposed in April.Pacific Edge's chief executive, Peter Meintjes, told the NZX on Wednesday that the company is pleased with the recommendation and final price.“We have invested significant resources in Triage Plus &nd...